Ontology highlight
ABSTRACT:
SUBMITTER: Polissidis A
PROVIDER: S-EPMC7355671 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
Polissidis Alexia A Petropoulou-Vathi Lilian L Nakos-Bimpos Modestos M Rideout Hardy J HJ
Biomolecules 20200616 6
Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson's disease (PD) and must be developed concurrently because of their interdependent relationship: biomarkers for the early detection of disease (i.e., prior to overt neurodegeneration) are necessary in order for patients to receive maximal therapeutic benefit and vice versa; disease-modifying therapies must become available for patients whose potential for disease diagnosis and prognosis ca ...[more]